This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
23 Mar 2022  |  North America  |  Market Outlook
Global Digital Health Outlook, 2022
Innovative Business Models of Remote Patient Monitoring Solutions Go beyond Chronic Care Management and Across the Care Continuum
Digital health offered extensive support and grew stronger as the pandemic continued with several variants across the globe. Telehealth and other enterprise IT solutions continued to be the backbone for healthcare systems, and access to health in the hands of the patients empowered consumers to manage their health with the best of tools. As the dem...
$4,950.00 -
14 Mar 2022  |  North America  |  Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00 -
11 Mar 2022  |  North America  |  Market Outlook
Global Medical Devices Outlook, 2022
Digital Efficiency Solutions for Operating Rooms and Competitive Intensity are Opening up New Growth Opportunities
As the healthcare sector adapts to the changes induced by the COVID-19 pandemic, the global medical devices industry is undergoing a major transformation in terms of business models, technology adoption, and care delivery approaches, among other areas. 2022 will prove to be another challenging year for medtech as uncertainties pertaining to COVID-1...
$4,950.00 -
08 Mar 2022  |  North America  |  Mega Trends
US Clinical Decision Support System (CDSS) Growth Opportunities
Sparking Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency among Providers and Payers and Improve the Patient Journey
Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform. This repo...
$4,950.00 -
08 Mar 2022  |  North America  |  Market Outlook
Global Pharmaceuticals Outlook, 2022
The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders
Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...
$4,950.00 -
03 Mar 2022  |  North America  |  Mega Trends
Global eClinical Solutions Growth Opportunities
Decentralized Clinical Trials, Rising Mobile Health Adoption, and Cloud-based Platforms Lower Costs and Enhance Efficiency
The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...
$4,950.00 -
28 Feb 2022  |  North America  |  Mega Trends
Growth Opportunities for Platform Approaches in Healthcare, Global
Digital Technologies, User Experience, and Clinical Expertise Will Drive Transformational Growth
Despite being one of the largest and fastest-growing industries, healthcare is too often slow to innovate. Healthcare services and data are both extremely fragmented, often work in silos, create process inefficiencies, and constrain access and affordability. Digital platforms offer integration and interoperability between applications and solut...
$2,450.00 -
28 Feb 2022  |  North America  |  Mega Trends
United States Clinical Laboratory Services Growth Opportunities
Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites
The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to...
$2,450.00 -
22 Feb 2022  |  North America  |  Mega Trends
Global Molecular Imaging Procedures Growth Opportunities
The Development of Novel Radiopharmaceuticals and the Expanding Clinical Applications for Molecular Imaging Equipment will Create Opportunities for the Growth of Procedures
This Frost & Sullivan research service presents an analysis of the global molecular imaging (MI) procedures market and an overview of the development of novel radiopharmaceuticals. It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. The study also outlines healthcare infrastructure and MI procedure vo...
$2,450.00 -
22 Feb 2022  |  North America  |  Mega Trends
United States Liquid Biopsy Growth Opportunities
Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape
Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...
$4,950.00